References
- Forrest DM, Seminari E, Hogg RS, et al. The incidence and spectrum of AIDS-defining illnessess in persons treated with antiretroviral drugs. Clin Infect Dis 1998; 27: 1379–1385.
- Floridia M, Fragola V, Galluzzo CM, et al. HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of 50 cells/pL): an analysis of 338 clinical events from a randomized clinical trial. HIV Med 2002; 3: 75–84.
- Castelnuovo B, Chiesa E, Rusconi S, et al. Declining incidence of AIDS and increasing prevalence of AIDS presen-ters among AIDS patients in Italy. Eur J Clin Microbiol Infect Dis 2003; 22: 663–669.
- Reed JA, Slater LN, Hemann BA, Brigati DJ. Dual organism infection in biopsy specimens from immunocompro-mised patients: two cases demonstrated by immunocytochem-istry. Clin Lab Anal 1993; 7: 168–173.
- Mocroft A, Oancea C, Van Lunzen J, et al. Decline in esophageal candidiasis and use of antimycotics in European patients with HIV. Am J Gastroenterol 2005; 100: 1446–1454.
- Manfredi R, Calza L, Chiodo F. Dual Candida albicans and Cryptococcus neoformans fungaemia in an AIDS presen-ter: a inique association in the highly active antiretroviral ther-apy (HAART) era. J Med Microbiol 2002; 51: 1135–1137.
- Manfredi R, Calza L, Chiodo F. Three to seven concur-rent AIDS-defining disorders at first hospitalization of AIDS presenters as an unexpected emerging feature during the era of highly active antiretroviral therapy. AIDS 2002; 16: 2356–2358.
- Garbino J, Kolarova L, Lew D, Hirschel B, Rohner P. Fungemia in HIV-infected patients: a 12-year study in a ter-tiary care hospital. AIDS Patient Care STDs 2001; 15: 407–410.
- Cain LE, Cole SR, Chmiel JS, Margolick JB, Rinaldo CR Jr, Detels R. Effect of active antiretroviral therapy on mul-tiple AIDS-defining illnesses among male HIV seroconverters. Am J Epidemiol 2006; 163: 310–315.